Evidence map›Paper›PMID 39179298›Full record

ArticleAJNR. American journal of neuroradiology2025

Radiomics-Based Differentiation of Glioblastoma and Metastatic Disease: Impact of Different T1-Contrast-Enhanced Sequences on Radiomics Features and Model Performance.

Girish Bathla, Camila G Zamboni, Nicholas Larson, Yanan Liu, Honghai Zhang, Nam H Lee, Amit Agarwal, Neetu Soni, Milan Sonka

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Girish BathlaFrom the Department of Radiology (G.B., C.G.Z.), University of Iowa Hospitals and Clinics, Iowa City, Iowa.ORCID 0000-0003-3170-242X
Camila G ZamboniFrom the Department of Radiology (G.B., C.G.Z.), University of Iowa Hospitals and Clinics, Iowa City, Iowa.ORCID 0000-0002-2365-7908
Nicholas LarsonDivision of Clinical Trials and Biostatistics (N.L.), Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-3468-4215
Yanan LiuCollege of Engineering (Y.L., H.Z., N.H.L., M.S.), University of Iowa, Iowa City, Iowa.
Honghai ZhangCollege of Engineering (Y.L., H.Z., N.H.L., M.S.), University of Iowa, Iowa City, Iowa.ORCID 0000-0003-0662-9865
Nam H LeeCollege of Engineering (Y.L., H.Z., N.H.L., M.S.), University of Iowa, Iowa City, Iowa.ORCID 0000-0003-2556-7612
Amit AgarwalDivision of Neuroradiology (A.A., N.S.), Department of Radiology, Mayo Clinic, Jacksonville, Florida.ORCID 0000-0001-9139-8007
Neetu SoniDivision of Neuroradiology (A.A., N.S.), Department of Radiology, Mayo Clinic, Jacksonville, Florida Soni.neetu@mayo.edu.ORCID 0000-0003-2082-1634
Milan SonkaCollege of Engineering (Y.L., H.Z., N.H.L., M.S.), University of Iowa, Iowa City, Iowa.

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
6 · The paper itself

Abstract

background and purposeEven though glioblastoma (GB) and brain metastases (BM) can be differentiated using radiomics, it remains unclear if the model performance may vary based on the contrast-enhanced sequence used. Our aim was to evaluate the radiomics-based model performance for differentiation between GB and brain metastases BM using MPRAGE and volumetric interpolated breath-hold examination (VIBE) T1-contrast-enhanced sequence. MATERIALS AND

methodsT1 contrast-enhanced (T1-CE) MPRAGE and VIBE sequences acquired in 108 patients (31 GBs and 77 BM) during the same MRI session were retrospectively evaluated. After standardized image preprocessing and segmentation, radiomics features were extracted from necrotic and enhancing tumor components. Pearson correlation analysis of radiomics features from tumor subcomponents was also performed. A total of 90 machine learning pipelines were evaluated using a 5-fold cross-validation. Performance was measured by mean area under the curve (AUC)-receiver operating characteristic (ROC), log loss, and Brier scores.

resultsA feature-wise comparison showed that the radiomics features between sequences were strongly correlated, with the highest correlation for shape-based features. The mean AUC across the top 10 pipelines ranged between 0.851 and 0.890 with T1-CE MPRAGE and between 0.869 and 0.907 with the T1-CE VIBE sequence. The top-performing models for the MPRAGE sequence commonly used support vector machines, while those for the VIBE sequence used either support vector machines or random forest. Common feature-reduction methods for top-performing models included linear combination filter and least absolute shrinkage and selection operator for both sequences. For the same machine learning feature-reduction pipeline, model performances were comparable (AUC-ROC difference range, -0.078-0.046).

conclusionsRadiomics features derived from T1-CE MPRAGE and VIBE sequences are strongly correlated and may have similar overall classification performance for differentiating GB from BM.

Indexed as

Brain NeoplasmsGlioblastomaImage Interpretation, Computer-AssistedMagnetic Resonance ImagingAdultAgedContrast MediaDiagnosis, DifferentialFemaleHumansMachine LearningMaleMiddle AgedRadiomicsReproducibility of ResultsRetrospective StudiesContrast Media

Identifiers

PMID39179298
PMCPMC11878985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.